Resveratrol & Natur Polyphenols: Mech of Proteolitic Clear of AB/Marambaud, Phil
白藜芦醇
基本信息
- 批准号:7439866
- 负责人:
- 金额:$ 15.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-01 至 2012-08-31
- 项目状态:已结题
- 来源:
- 关键词:AgingAlzheimer&aposs DiseaseAmyloidAnimal ModelAntioxidantsAppendixBindingBiodistributionBiologicalBiological AvailabilityBrainCell Culture SystemCognitiveComplementary and alternative medicineConsumptionCultured CellsDataDepositionDeteriorationDiseaseEndopeptidasesEpidemiologic StudiesGlucuronidesGoalsIn VitroInorganic SulfatesLiquid ChromatographyMediatingMethodsModelingMolecularNerve DegenerationOrganismPatientsPeptide HydrolasesPeptidesPeripheralPlasminPreventionProcessPropertyResveratrolRiskRodentRodent ModelRoleSafetyStressTestingTg2576TissuesTransgenic MiceUnspecified or Sulfate Ion SulfatesWineaccelerator mass spectrometryglucuronideimprovedin vivomedical schoolsmouse modelnovelpolyphenolresponse
项目摘要
Concordant epidemiological studies have demonstrated that moderate consumption of wine reduces the risk
of developing Alzheimer's disease. Several antioxidant polyphenols occur in abundance in wine and are
suspected to contribute to the beneficial effect of wine consumption in Alzheimer's disease. Despite
skepticism concerning the bioavailability of these polyphenols, recent in vivo data have clearly demonstrated
the neuroprotective properties of the naturally occurring polyphenol resveratrol in rodent models for stress
and diseases, and consequently, a safety-efficacy study in Alzheimer's disease patients treated with
resveratrol is currently conducted at the Mount Sinai School of Medicine. However, the exact molecular
mechanisms involved in the beneficial properties of resveratrol and other natural polyphenols on the
neurodegenerative process in Alzheimer's disease brain, remain to be clearly defined. Our recent data have
revealed that resveratrol (frans-3,4',5-trihydroxystilbene) markedly lowers the levels of amyloid-p peptides in
cell culture systems (see appendix 1). The long-term goal of this application is to elucidate the bioavailability
of resveratrol and its metabolites in rodents and to characterize their anti-amyloidogenic properties in vitro
and in vivo as a necessary prerequisite to the identification of novel complementary and alternative
medicines for the prevention of the neurodegenerative mechanisms associated with Alzheimer's disease.
一致的流行病学研究表明,适度饮用葡萄酒可以降低风险
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Giulio Maria Pasinetti其他文献
Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease
- DOI:
10.1016/0169-328x(95)00097-c - 发表时间:
1995-10-01 - 期刊:
- 影响因子:
- 作者:
Philippe Bertrand;Judes Poirier;Tomiichiro Oda;Caleb E. Finch;Giulio Maria Pasinetti - 通讯作者:
Giulio Maria Pasinetti
Differential susceptibility to repeated social stress induces synaptic plasticity impairment and cognitive deficit in the 5xFAD mouse model
对重复社会应激的差异易感性在 5xFAD 小鼠模型中诱导突触可塑性损伤和认知缺陷
- DOI:
10.1016/j.pneurobio.2025.102797 - 发表时间:
2025-08-01 - 期刊:
- 影响因子:6.100
- 作者:
Eun-Jeong Yang;Md Al Rahim;Sibilla Masieri;Giulio Maria Pasinetti - 通讯作者:
Giulio Maria Pasinetti
The Role of the Neural Exposome as a Novel Strategy to Identify and Mitigate Health Inequities in Alzheimer’s Disease and Related Dementias
- DOI:
10.1007/s12035-024-04339-6 - 发表时间:
2024-07-05 - 期刊:
- 影响因子:4.300
- 作者:
Ravid Granov;Skyler Vedad;Shu-Han Wang;Andrea Durham;Divyash Shah;Giulio Maria Pasinetti - 通讯作者:
Giulio Maria Pasinetti
61 Repurposing anti-hypertensive drugs for Alzheimer's disease
- DOI:
10.1016/j.neurobiolaging.2012.01.079 - 发表时间:
2012-05-01 - 期刊:
- 影响因子:
- 作者:
Giulio Maria Pasinetti;P. Rosenberg - 通讯作者:
P. Rosenberg
P27-030-23 Flavonoids Ameliorate Stress-Induced Depression by Preventing NLRP3 Inflammasome Priming
- DOI:
10.1016/j.cdnut.2023.101237 - 发表时间:
2023-07-01 - 期刊:
- 影响因子:
- 作者:
Giulio Maria Pasinetti;Eun-Jeong Yang - 通讯作者:
Eun-Jeong Yang
Giulio Maria Pasinetti的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Giulio Maria Pasinetti', 18)}}的其他基金
Validation of Immune Dysfunction in Model of Social Stress: Implications for Major Depression Disorder in Veterans
社会压力模型中免疫功能障碍的验证:对退伍军人重度抑郁症的影响
- 批准号:
10293590 - 财政年份:2021
- 资助金额:
$ 15.23万 - 项目类别:
Validation of Immune Dysfunction in Model of Social Stress: Implications for Major Depression Disorder in Veterans
社会压力模型中免疫功能障碍的验证:对退伍军人重度抑郁症的影响
- 批准号:
10618776 - 财政年份:2021
- 资助金额:
$ 15.23万 - 项目类别:
Validation of Immune Dysfunction in Model of Social Stress: Implications for Major Depression Disorder in Veterans
社会压力模型中免疫功能障碍的验证:对退伍军人重度抑郁症的影响
- 批准号:
10016566 - 财政年份:2021
- 资助金额:
$ 15.23万 - 项目类别:
Administrative, Biostatistics, and Management Core
行政、生物统计和管理核心
- 批准号:
10200690 - 财政年份:2020
- 资助金额:
$ 15.23万 - 项目类别:
Suppression of Immune Signatures of Stress by Polyphenols Supplements
多酚补充剂抑制压力的免疫特征
- 批准号:
10447073 - 财政年份:2020
- 资助金额:
$ 15.23万 - 项目类别:
Suppression of Immune Signatures of Stress by Polyphenols Supplements
多酚补充剂抑制压力的免疫特征
- 批准号:
10671048 - 财政年份:2020
- 资助金额:
$ 15.23万 - 项目类别:
Administrative, Biostatistics, and Management Core
行政、生物统计和管理核心
- 批准号:
10447076 - 财政年份:2020
- 资助金额:
$ 15.23万 - 项目类别:
Suppression of Immune Signatures of Stress by Polyphenols Supplements
多酚补充剂抑制压力的免疫特征
- 批准号:
10200686 - 财政年份:2020
- 资助金额:
$ 15.23万 - 项目类别:
Administrative, Biostatistics, and Management Core
行政、生物统计和管理核心
- 批准号:
10671063 - 财政年份:2020
- 资助金额:
$ 15.23万 - 项目类别:
CMA: Immune/inflammatory priming in exacerbating responses to GWVI stressors: implications for GWVI treatments
CMA:免疫/炎症引发加剧对 GWVI 应激源的反应:对 GWVI 治疗的影响
- 批准号:
10752604 - 财政年份:2019
- 资助金额:
$ 15.23万 - 项目类别:














{{item.name}}会员




